Business · 18/03/2026Updated: 10/16/2026 · 1 min read
FDA Clears Methylergonovine Maleate Injection for Approval
Summary
The FDA has determined that METHERGINE injection, 0.2 mg/mL, was not withdrawn from sale due to safety or effectiveness concerns, paving the way for potential approval of generic versions.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →